This bill amends existing pharmacy laws to enhance the practice of pharmacy and the dispensing of medications. It allows licensed health care professionals to dispense up to a 30-day supply of noncontrolled oral anti-cancer medications, contingent upon the presence of a full-time licensed pharmacist for consultation. The bill also modifies display requirements for licenses, permitting them to be readily retrievable rather than conspicuously displayed, and allows licensed advanced pharmacy technicians to engage in remote processing. Additionally, it removes the requirement for a pharmacist's name or initials on labels for controlled drugs and broadens the definition of the "practice of pharmacy" to include a wider range of patient care services.

Furthermore, the bill eliminates the examination requirement for advanced pharmacy technician licensure and prohibits the pharmacy board from testing applicants on pharmacy jurisprudence or law. It reduces the board's authority regarding collaborative pharmacy practice agreements and clarifies its rulemaking authority concerning education and training standards for pharmacists. The bill also introduces provisions that clarify the responsibilities of licensed pharmacists regarding the delegation of certain acts, emphasizing the importance of professional judgment and accountability in these decisions. The effective date of this act is set for 60 days after its passage. No specific deletions from current law are noted in the provided text.

Statutes affected:
Introduced: 318:42, 318:28, 318:39, 318:15-, 318-B:13, 318:5-a, 318:16-a
As Amended by the Senate: 318:42, 318:28, 318:39, 318:15-, 318-B:13, 318:5-a, 318:16-a, 318:19, 318:8
SB504 text: 318:42, 318:28, 318:39, 318:15-d, 318-B:13, 318:5-a, 318:16-a